Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
about
Novel technologies and emerging biomarkers for personalized cancer immunotherapyHigh Content Imaging (HCI) on Miniaturized Three-Dimensional (3D) Cell CulturesOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacyQuantification of dynamic morphological drug responses in 3D organotypic cell cultures by automated image analysisA 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatmentTowards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans.Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues.Transfer, imaging, and analysis plate for facile handling of 384 hanging drop 3D tissue spheroidsDevelopment of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells.Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactorHigh-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.Characterising the tumour morphological response to therapeutic intervention: an ex vivo model.Three-dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer.Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.3D in vitro tissue models and their potential for drug screening.Cell and tissue engineering for liver disease.Development of a 3D angiogenesis model to study tumour - endothelial cell interactions and the effects of anti-angiogenic drugs.Evaluation of assays for drug efficacy in a three-dimensional model of the lung.Human proximal tubule cells form functional microtissues.Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink.Digital microfluidics for automated hanging drop cell spheroid culture.Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis.A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications.A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay.OrganDots--an organotypic 3D tissue culture platform for drug development.Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening.Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro.Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model.In situ patterned micro 3D liver constructs for parallel toxicology testing in a fluidic device.A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening.Manipulating magnetic 3D spheroids in hanging drops for applications in tissue engineering and drug screening.Microfluidic device flow field characterization around tumor spheroids with tunable necrosis produced in an optimized off-chip process.3D cell culture systems--towards primary drug discovery platforms: an interview with Heinz Ruffner (Novartis) and Jan Lichtenberg (InSphero).In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.Environmental Toxin Screening Using Human-Derived 3D Bioengineered Liver and Cardiac Organoids.Iterative Cellular Screening System for Nanoparticle Safety Testing
P2860
Q26770780-EC7D73C2-2415-4587-9737-D0EC7A3DFBB9Q26773298-B6EF0FB9-1A90-4FD4-ADE9-0E5402FD707AQ26826863-8035357F-4610-46FD-BEE8-E506AA274FB9Q28538607-13CD2E6E-86E0-4E63-A819-FA3C5322D290Q28641649-A0196D5A-3B27-422B-9E8E-6EFDB100D140Q33641648-63BB1D9F-5095-42C6-B2D1-CF4C53179FF8Q34063544-91FF028F-2699-43D8-A560-B3A9C3FA3BD8Q34078285-D3AF7612-C876-4620-85F0-5FD2F00422D2Q35129375-CBA1B8B3-13A2-43C2-9BD7-E2E968E6B818Q35745230-2FD4F7ED-9B5E-463A-8FFE-E5DE6EAA55A3Q35759165-63857F9B-63C6-4A8D-9F48-C5F7F741D7E3Q36486054-A2B0E41F-C87C-455F-8220-F2B07F4D8C69Q36797292-E38DB4D2-7849-48B0-83E0-DC99F3A2F6E6Q38116928-7731201B-E051-4812-A2CC-B4F62EDE4A43Q38154340-2C4CE151-D89F-4BFA-9FF7-99BBC048BB41Q38230357-1B91F1A2-9374-402D-9396-BFB798727F39Q38700897-169CF07F-AAA9-4ADB-9313-86EC97BCC35EQ38757759-512E61F2-54B7-464B-AD7D-7F89E81AE787Q38811094-0DB6E4DB-3095-4EAF-A401-404C3A5192FAQ38868772-B2A28851-1FE8-446F-BCB8-0F0F552ECA42Q38928428-B774D04C-D220-4752-B0B0-1EEDFC371134Q38954660-7D3DC43E-D5B5-484A-9ADA-331D75F3E27CQ38979749-1ACFEABA-C6B3-48E0-93E4-0BE33AD8750DQ39089853-4C845500-E6A2-43BD-ADB9-9A68E857BB53Q39117403-037B0A06-AAB6-4F3F-93C0-2DE342EB1D7BQ39615996-34521ABA-B9F8-4127-AB52-9E17E6EEEE0EQ40523179-08B8A4BB-12C7-4113-915F-6A35FB8AAE49Q40965247-C45E784D-558B-4144-8D85-BA16BE08C4D6Q41459060-FA2F189E-6698-43D8-A97C-0B6707B4B3D2Q42584397-759B3B5A-2A04-42CC-8F62-F4688ACF2122Q42621191-1809E462-5A54-4849-9B2B-C17B5C109B49Q45018911-E330814B-FAD1-49A5-89F7-0CCB510AAB4FQ45027671-E5642466-8E4C-4CCC-92FA-52CD6CB3C056Q45338396-AD5ABA59-EB3D-4828-BB5D-5D977E27070EQ47781401-E20317BC-27BE-4798-9E05-881F067B2CA0Q48420341-34134236-3153-4E51-BA9B-E1CE41793DACQ49542418-9F58D8FC-8130-4B6E-BDAC-16664EA8D607Q55332491-65BDC43F-A285-456F-A90D-BDEBD7EBD4B5Q59113954-D09C8A3C-99E1-4D07-B72B-961EC297589D
P2860
Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Towards automated production a ...... spherical tumor microtissues.
@en
Towards automated production a ...... spherical tumor microtissues.
@nl
type
label
Towards automated production a ...... spherical tumor microtissues.
@en
Towards automated production a ...... spherical tumor microtissues.
@nl
prefLabel
Towards automated production a ...... spherical tumor microtissues.
@en
Towards automated production a ...... spherical tumor microtissues.
@nl
P2093
P2860
P356
P1476
Towards automated production a ...... spherical tumor microtissues.
@en
P2093
Jan Lichtenberg
Jens M Kelm
Manuela Bieri
Maren Drewitz
Marianne Helbling
Nicole Fried
P2860
P304
P356
10.1002/BIOT.201100290
P577
2011-11-21T00:00:00Z